MINNEAPOLIS, May 15 /PRNewswire-FirstCall/ -- Biotel Inc. announces sales for the third quarter ended March 31, 2006, having attained revenues of $2,469,000 versus $2,248,000 for the quarter ended March 31, 2005. Net earnings for the quarter ended March 31, 2006 were $130,000 compared to $3,000 for the quarter ended March 31, 2005. Revenues and net income for the nine months ended March 31, 2006 were $7,488,000 and $426,000, respectively, versus revenues and net income of $7,336,000 and $229,000, respectively, for the nine months ended March 31, 2005.
Biotel President and CEO Steve Springrose said, "Biotel continues to advance in accordance with its plans to become a development partner for medical corporations seeking new devices and clinical services. Biotel has a strong position as a contract manufacturer of battery powered ECG diagnostic devices, liposuction equipment, and ECG research services for manufacturers evaluating products and collecting patient ECG information to be submitted to FDA. Biotel's portfolio of products offered to diagnostic cardiology and cosmetic surgery manufacturers is expanding, with the development of Braemar's new Holter and event recording devices and a new portable unit for liposuction procedures. Our Agility clinical ECG research subsidiary has continued its progress in signing contracts and supporting clinical trials utilizing Holter and event recorder data collection and management. Agility believes it is now the nation's largest contractor of ECG services for new medical devices being clinically evaluated for performance to control atrial fibrillation, a difficult to manage cardiac rhythm disturbance. We are happy to see our continued growth and profitability."
Biotel provides complete medical devices and services to medical corporations seeking to outsource research, development and manufacturing capabilities. Biotel subsidiaries design, accomplish regulatory approval, manufacture, and test medical devices such as: 24- and 48-hour Holter recorders, 30-day ECG event recorders, tissue extraction components, and flow control devices; provide 24/7 clinical ECG research services and Internet technologies; and develop, service, and test other custom medical devices.
3 months ended 3 months ended % March 31, 2006 March 31, 2005 Change Revenues $2,469,000 $2, 248,000 +9.8 % Net Income $130,000 $3,000 +4233 % Earnings Per Share, Basic $0.05 $0.00 Earnings Per Share, Diluted $0.05 $0.00 9 months ended 9 months ended % March 31, 2006 March 31, 2005 Change Revenues $7,488,000 $7,336,000 +2.1 % Net Income $426,000 $229,000 +86.0 % Earnings Per Share, Basic $0.16 $0.09 Earnings Per Share, Diluted $0.15 $0.08 For further information, contact Judy Naus at 651-286-8623 or info@biotelinc.com
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.
Biotel Inc.CONTACT: Judy Naus, Biotel, +1-651-286-8623, info@biotelinc.com
